Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PMS2P9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LIG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCRL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGAPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM134A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XYLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EZH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NEU3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM200B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100287290 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on